Stability testing is a critical part of pharmaceutical product development and regulatory compliance. It helps determine whether a product remains safe, effective, and stable throughout its intended shelf life under recommended storage conditions. In Singapore, pharmaceutical products regulated by the Health Sciences Authority (HSA) are commonly required to undergo stability studies to support product registration and expiry date claims.
HSA generally follows the stability testing guidelines established by the International Council for Harmonisation. These guidelines outline the storage conditions, testing intervals, and parameters required to evaluate pharmaceutical product stability.
Common stability study conditions include long-term stability testing at 30°C / 75% RH and accelerated stability testing at 40°C / 75% RH. These studies help manufacturers assess how environmental factors such as temperature and humidity affect product quality over time.
Pharmaceutical products may undergo physical, chemical, or microbiological changes during storage. Stability testing helps ensure that the product maintains its quality, potency, safety, and performance throughout its shelf life.
Stability studies are important for:
Depending on the product type, stability testing may include:
These parameters help determine whether the product remains within acceptable specifications over time.
Stability testing is commonly conducted for:
Different dosage forms may require different testing conditions and evaluation criteria.
Pharmaceutical stability testing plays an essential role in ensuring product safety, quality, and regulatory compliance. By conducting stability studies according to HSA and ICH guidelines, manufacturers can support product shelf life claims and ensure consumers receive products that remain effective and reliable throughout storage and distribution.
Let our accredited laboratory handle your long-term and accelerated stability studies to secure smooth regulatory approval.